Navigation Links
DRAXIS Health Reports Fourth Quarter and Year End Results
Date:2/7/2008

Since the vast majority of the Company's cost structure is in

Canadian dollars and a larger portion of the Company's revenue

stream is denominated in U.S dollars, the strengthening of the

Canadian dollar has a significant negative impact on the Company's

underlying gross profit margin and operating expenses. We estimate

the strengthening of the Canadian dollar has reduced operating

profitability by approximately 3 to 4 cents per share on an annual

basis relative to 2006.

- Volumes of radioactive products produced by the radiopharmaceutical

operations were lower than expected for the second half of 2007 due

to a decision by a customer to cease production of a private label

radioactive product (which historically represented $350,000 in

revenues per quarter) while the customer determines whether to

continue to supply the market in the future pending possible

formulation changes.

- During the course of 2007, two separate shortages for the supply of

radioactive isotopes occurred which impacted the financial

performance of the radiopharmaceutical segment. The first shortage

resulted in the Company obtaining the approval of a secondary source

of supply for the U.S. market. The second shortage created an

industry wide decrease in demand in late 2007 for radioactive

procedures due to a short supply in the market place of

radioisotopes, being the key ingredient.

- Hectorol(R) production volumes in 2007 were $9 million lower than

what they were in 2006 and significantly lower than what was

originally forecasted for 2007. It is our understanding that these

volumes may still vary materially either positively or negatively in

future quarters as a result of continued uncertainty in custome
'/>"/>

SOURCE DRAXIS Health Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33

Related medicine news :

1. Draxis Health selected by Johnson and Johnson Consumer Companies, Inc. for major contract manufacturing relationship
2. DRAXIS to Present at the 2007 UBS Global Life Sciences Conference
3. DRAXIS Health Inc. Announces Retirement of Dr. Martin Barkin as President and Chief Executive Officer
4. DRAXIS Names GE Healthcare as Exclusive Distributor of DRAXIMAGE(R) Sestamibi in USA
5. DRAXIS Announces Application for Normal Course Issuer Bid
6. DRAXIS Share Buyback Approved by TSX
7. DRAXIS to Report Fourth Quarter and Year End 2007 Results on February 7th
8. Penn study finds pro-death proteins required to regulate healthy immune function
9. UCLA researchers identify markers that may predict diabetes in still-healthy people
10. Air pollution linked to cardiovascular risk indices in healthy young adults
11. More proof needed of safety and quality of electronic personal health records
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2014)... CITY, GA (PRWEB) September 02, 2014 Last ... whole new level with the launch of a luxurious line ... to announce that the SEA ISLAND COTTON Socks are joining ... compression level, giving more people the comfort of natural cotton ... COTTON Socks, they are surprised to find socks as soft ...
(Date:9/2/2014)... FL (PRWEB) September 02, 2014 Alliance ... targeting and multi-channel email marketing is pleased to announce ... market, Firearms & Freedom as well as ... properties represent more than one million concerned Americans who ... advertising. , “We are honored to continue providing ...
(Date:9/2/2014)... hospitalized, but your outpatient doctor does not know? ... follow-up care, but your doctor does not have ... Missing or incomplete communication from hospitals to outpatient ... experiences and lead to hospital readmissions. , ... can improve hospitals, communication during patient care transitions. ...
(Date:9/2/2014)... many health risks, including heart disease and diabetes, but ... to mitigate one often-overlooked risk: not buckling up in ... H. Jacobson, a professor of computer science and of ... with a decrease in seatbelt usage. However, these effects ... , "Primary seatbelt laws lead to increased use of ...
(Date:9/2/2014)... Farmington, New York (PRWEB) September 02, 2014 ... Millworks is making it easy to create a consistent look ... the physical structure, to the floor you walk on and ... shop for all custom reclaimed wood designs. , “We’re ... customers to our product line. It saves time, adds consistency, ...
Breaking Medicine News(10 mins):Health News:SIGVARIS’ Luxury Line of Compression Socks, SEA ISLAND COTTON, Now Available in Stronger Compression Level 2Health News:ASG Continues to Bring New Lists to Market 2Health News:ASG Continues to Bring New Lists to Market 3Health News:Can data motivate hospital leaders to improve care transitions? 2Health News:Seatbelt laws encourage obese drivers to buckle up 2Health News:Pioneer Millworks Now Offering Products Beyond Reclaimed Wood Flooring 2
... The Advertising Standards Authority ruled yesterday that a Walkers ... salt content.// ,According to the industry watchdog ... in its crisps to "7% of your guideline daily ... did not apply to all Walkers crisps. They have ...
... scheme launched in Madhya Pradesh to help malnourished children is ... Shakti scheme was unveiled to aid the 5.7 million malnourished ... years in age, Grassroots Features reported. ,Two-and-a-half-year-old Prem ... 4.2 kg when she was brought to the Bal Shakti ...
... to a new study at the University of Michigan Depression ... not getting// any treatment nor are the ones with the ... ,In the latest issue of General Hospital Psychiatry, the ... of treatment, are not getting enough. ,Without adequate treatment ...
... Bill Gates said inadequate access to treatment and continued discrimination ... in addresses to the largest ever AIDS conference under way ... stigma and stop people from being scared to know their ... Gates have donated billions of dollars to combat the spread ...
... the use of Herceptin in advanced breast cancer patients led ... percent of patients treated with Herceptin// , which no ... of the damage to the heart can be remedied with ... in the Journal of Clinical Oncology, concludes that use of ...
... that reduced levels of testosterone, which is the male sex ... whether a man would die early. ,US scientists ... 858 military veterans aged over 40. Reporting their findings in ... low hormone levels had an 88% increased risk of death ...
Cached Medicine News:Health News:Scheme for Combating Malnourishment in MP Children Yet to Pick Up 2Health News:No therapy for most of the pregnant women with depression 2Health News:No therapy for most of the pregnant women with depression 3Health News:No therapy for most of the pregnant women with depression 4Health News:Herceptin Use May Enhance Cardiac Toxicity, Study 2Health News:Herceptin Use May Enhance Cardiac Toxicity, Study 3Health News:Low Testosterone Linked With Early Death 2
(Date:9/2/2014)...  Boston Scientific Corporation (NYSE: BSX ... purchase the Interventional business of Bayer AG. The ... offer physicians and healthcare systems a more complete ... The addition of the Bayer Interventional ... Boston Scientific strategy to provide a comprehensive portfolio ...
(Date:9/2/2014)... , Sept. 2, 2014  Volcano Corporation ... focused on improving patient and economic outcomes on ... minimally invasive coronary and peripheral visualization, physiology diagnostics ... participating in the Morgan Stanley Healthcare conference on ... Scott Huennekens , president and chief executive ...
(Date:9/2/2014)... SAN DIEGO , Sept. 2, 2014  Arena ... that the US Food and Drug Administration (FDA) has ... of pulmonary arterial hypertension. "The FDA ... clinical data submissions from sponsors to identify and designate ... help advance the evaluation and development of such products," ...
Breaking Medicine Technology:Boston Scientific Closes Acquisition Of Interventional Business Of Bayer AG 2Boston Scientific Closes Acquisition Of Interventional Business Of Bayer AG 3Boston Scientific Closes Acquisition Of Interventional Business Of Bayer AG 4Boston Scientific Closes Acquisition Of Interventional Business Of Bayer AG 5Arena Pharmaceuticals' APD811 Granted Orphan Drug Status for Pulmonary Arterial Hypertension 2Arena Pharmaceuticals' APD811 Granted Orphan Drug Status for Pulmonary Arterial Hypertension 3Arena Pharmaceuticals' APD811 Granted Orphan Drug Status for Pulmonary Arterial Hypertension 4
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: